Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REVERSE study of tacrolimus-to-cyclosporine conversion for post-transplant diabetes
2006-001765-42Phase 4Completed
- Sponsor
- UZ Brussel
- Start
- Jan 2007
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in post-transplantation diabetes mellitus (PTDM) comparing Conversion to cyclosporine A with Continue tacrolimus control (2 arms). Primary endpoint: Diabetes remission at 1 year. Started Jan 2007; status: completed.
02
Drugs
cyclosporinetacrolimus
03
Conditions
post-transplantation diabetes mellitus (PTDM)
Beyond the preview
Go deeper on 2006-001765-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001765-42.